1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Ruiz-Galiana, Julian, Canton, Rafael, De Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Hernandez-Sampelayo, Teresa, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Martin-Delgado, Mari Cruz, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Rodriguez Fernandez, Rosa, Kestler, Marta, Bouza, Emilio.

    Respiratory syncytial virus: A new era

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 37(2): 134-148.

    [doi:10.37201/req/147.2023]

  • Benito, Natividad, Martinez-Pastor, Juan Carlos, Lora-Tamayo, Jaime, Ariza, Javier, Baeza, Jose, Belzunegui-Otano, Joaquin, Cobo, Javier, del-Toro, Maria-Dolores, Fontecha, Cesar G., Font-Vizcarra, Lluis, Horcajada, Juan P., Morata, Laura, Murillo, Oscar, Nolla, Joan M., Nunez-Cuadros, Esmeralda, Pigrau, Carlos, Portillo, Maria Eugenia, Rodriguez-Pardo, Dolors, Sobrino-Diaz, Beatriz, Saavedra-Lozano, Jesus.

    Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 42(4): 208-214.

    [doi:10.1016/j.eimc.2023.07.003]

  • Berenguer J, Jarrín I, Bellón JM, Díez C, Jiménez-Sousa MA, López JC, Pinto-Martínez A, Moreno S, Montes ML, Iribarren JA, Orviz E, Portilla J, Villarroya F, Domingo P, Resino S.

    Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients with HIV.

    JOURNAL OF INFECTIOUS DISEASES . 230(2): 421-425.

    [doi:10.1093/infdis/jiae168]

  • Pinazo MJ, Forsyth C, Losada I, Esteban ET, García-Rodríguez M, Villegas ML, Molina I, Crespillo-Andújar C, Gállego M, Ballart C, Ramirez JC, Aden T, Hoerauf A, Pfarr K, Vaillant M, Marques T, Fernandes J, Blum B, Ribeiro I, Sosa-Estani S, Barreira F, Gascón J.

    Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.

    LANCET INFECTIOUS DISEASES . 24(4): 395-403. Nº de citas: 4

    [doi:10.1016/S1473-3099(23)00651-5]

  • Bosch-Nicolau P, Fernández ML, Sulleiro E, Villar JC, Perez-Molina JA, Correa-Oliveira R, Sosa-Estani S, Sánchez-Montalvá A, Del Carmen Bangher M, Moreira OC, Salvador F, Mota Ferreira A, Eloi-Santos SM, Serre-Delcor N, Ramírez JC, Silgado A, Oliveira I, Martín O, Aznar ML, Ribeiro ALP, Almeida PEC, Chamorro-Tojeiro S, Espinosa-Pereiro J, de Paula AMB, Váquiro-Herrera E, Tur C, Molina I.

    Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial.

    LANCET INFECTIOUS DISEASES . 24(4): 386-394. Nº de citas: 3

    [doi:10.1016/S1473-3099(23)00629-1]

  • Ligero-López J, Corbacho-Loarte MD, Antón-Berenguer V, Merino-Fernández FJ, Rubio-Muñoz JM, Valle-Borrego B.

    A 14-year review (2007-2020) of helminthiasis epidemiology in a hospital in Southern Madrid, Spain.

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 43(4): 659-671.

    [doi:10.1007/s10096-024-04746-6]

  • Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Garcia-Vidal C, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatii P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, Gudiol C.

    Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy.

    Microorganisms . 12(4): .

    [doi:10.3390/microorganisms12040705]

  • Tamarozzi F, Mazzi C, Antinori S, Arsuaga M, Becker SL, Bottieau E, Camprubi-Ferrer D, Caumes E, Duvignaud A, Grobusch MP, Jaureguiberry S, Jordan S, Mueller A, Neumayr A, Perez-Molina JA, Salas-Coronas J, Salvador F, Tomasoni LR, van Hellemond JJ, Vaughan SD, Wammes LJ, Zammarchi L, Buonfrate D, Huits R, van Lieshout L, Gobbi F.

    Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study.

    LANCET INFECTIOUS DISEASES . 24(10): 627-637. Nº de citas: 4

    [doi:10.1016/S1473-3099(24)00080-X]

  • Fortún J, Gómez-García de la Pedrosa E, Martínez-Lorca A, Paredes P, Martín-Dávila P, Gómez-López A, Buitrago MJ, López-Jiménez J, Gioia F, Escudero R, Alvarez-Alvarez ME, Soriano C, Moreno-García J, San Miguel D, Vicente N, Moreno S.

    A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis.

    JOURNAL OF FUNGI . 10(3): . Nº de citas: 1

    [doi:10.3390/jof10030191]

  • Ramírez-Olivencia G, Velasco Arribas M, Vera García MM, Casabona J, Martínez MJ, Membrillo De Novales FJ.

    Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study).

    Open forum infectious diseases . 11(3): .

    [doi:10.1093/ofid/ofae105]

  • Berenguer J, Aldámiz-Echevarría T, Hontañón V, Fanciulli C, Quereda C, Busca C, Domínguez L, Hernández C, Vergas J, Gaspar G, García-Fraile LJ, Díez C, De Miguel M, Bellón JM, Bañares R, González-García J.

    Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV coinfected patients with advanced Fibrosis/Cirrhosis.

    HEPATOLOGY . 81(1): 238-253. Nº de citas: 3

    [doi:10.1097/HEP.0000000000000838]

  • Escudero-Sanchez R, Ramos-Martínez A, Caballero-Bermejo AF, Díaz-Pollán B, Ruiz-Carrascoso G, Samperio MO, García PM, Amador PM, Romo FG, Segarra OM, Jiménez GN, Del Campo Albendea L, García AM, Cobo J.

    Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence.

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 43(3): 533-540.

    [doi:10.1007/s10096-024-04762-6]

  • Bierbrier R, Javelle E, Norman FF, Chen LH, Bottieau E, Schwartz E, Leder K, Angelo KM, Stoney R, Libman M, Hamer DH, Huits R, Connor BA, Simon F, Barkati S.

    Chikungunya infection in returned travellers: results from the GEOSENTINEL network, 2005-2020.

    JOURNAL OF TRAVEL MEDICINE . 31(2): . Nº de citas: 1

    [doi:10.1093/jtm/taae005]

  • Gioia F, Walti LN, Orchanian-Cheff A, Husain S.

    Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.

    LANCET RESPIRATORY MEDICINE . 12(3): 207-216. Nº de citas: 3

    [doi:10.1016/S2213-2600(23)00408-3]

  • Esteban-Cartelle B, Serrano DR, Pérez Menéndez-Conde C, Vicente-Oliveros N, Álvarez-Díaz A, Abete JF, Martín-Dávila P.

    Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology spectrum . 12(2): .

    [doi:10.1128/spectrum.02063-23]

  • Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, García de Viedma D, Bouza E.

    COVID-19: On the threshold of the fifth year. The situation in Spain.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 37(1): 17-28.

    [doi:10.37201/req/123.2023]

  • Ron R, Martínez-Sanz J, Herrera S, Ramos-Ruperto L, Díez A, Sainz T, Álvarez-Díaz N, Correa-Pérez A, Muriel A, López-Alcalde J, Pérez-Molina JA, Moreno S, Serrano-Villar S.

    CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis.

    Frontiers in immunology . 15: 1343124-1343124. Nº de citas: 1

    [doi:10.3389/fimmu.2024.1343124]

  • Ron R, Moreno E, Cancio-Suárez MR, Serrano-Villar S.

    The microbiome as a biomarker of anal precancerous lesions in people with HIV.

    CURRENT OPINION IN INFECTIOUS DISEASES . 37(1): 17-25.

    [doi:10.1097/QCO.0000000000000985]